Friday 31 May 2019

How BioMarin May Revolutionize the Hemophilia Treatment Market - Motley Fool

How BioMarin May Revolutionize the Hemophilia Treatment Market  Motley Fool

The latest trial results for its hemophilia A gene therapy suggest it may eliminate or significantly reduce the need for weekly infusions.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)